Evidence map›Paper›PMID 32979378›Full record

ArticleUrology2021

Deferring Elective Urologic Surgery During the COVID-19 Pandemic: The Patients' Perspective.

Riccardo Campi, Riccardo Tellini, Antonio Andrea Grosso, Daniele Amparore, Andrea Mari, Lorenzo Viola, Andrea Cocci, Paolo Polverino, Enrico Checcucci, Paolo Alessio and 5 more

Registry-linked trialAbstract readMulticenter Study
In one paragraph

Article in Urology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04924790 (The Effect of the COVID-19 Pandemic on Patient Preferences and Decision Making for Obstructive Urinary Stone Interventions), which is not on this map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04924790 unknown statusnot on this map

The Effect of the COVID-19 Pandemic on Patient Preferences and Decision Making for Obstructive Urinary Stone Interventions

TypeobservationalSponsorAnkara Training and Research HospitalRan2021 to 2022Enrolled158ConditionsUrinary Stone, Urinary Calculi, Covid19ArmsCOVID-19 Pandemic
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Counting the social, psychological, and economic costs of COVID-19 for cancer patients.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Pooled it
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Trends in urological emergencies in the Era of COVID-19.International braz j urol : official journal of the Brazilian Society of Urology
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Riccardo CampiDepartment of Urology, Careggi Hospital, University of Florence, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy. Electronic address: riccardo.campi@gmail.com.
Riccardo TelliniDepartment of Urology, Careggi Hospital, University of Florence, Florence, Italy.
Antonio Andrea GrossoDepartment of Urology, Careggi Hospital, University of Florence, Florence, Italy.
Daniele AmparoreDivision of Urology, Department of Oncology, School of Medicine, San Luigi Hospital, University of Turin, Orbassano, Turin, Italy.
Andrea MariDepartment of Urology, Careggi Hospital, University of Florence, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Lorenzo ViolaDepartment of Urology, Careggi Hospital, University of Florence, Florence, Italy.
Andrea CocciDepartment of Urology, Careggi Hospital, University of Florence, Florence, Italy.
Paolo PolverinoDepartment of Urology, Careggi Hospital, University of Florence, Florence, Italy.
Enrico CheccucciDivision of Urology, Department of Oncology, School of Medicine, San Luigi Hospital, University of Turin, Orbassano, Turin, Italy.
Paolo AlessioDivision of Urology, Department of Oncology, School of Medicine, San Luigi Hospital, University of Turin, Orbassano, Turin, Italy.
Cristian FioriDivision of Urology, Department of Oncology, School of Medicine, San Luigi Hospital, University of Turin, Orbassano, Turin, Italy.
Andrea MinerviniDepartment of Urology, Careggi Hospital, University of Florence, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Marco CariniDepartment of Urology, Careggi Hospital, University of Florence, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Francesco PorpigliaDivision of Urology, Department of Oncology, School of Medicine, San Luigi Hospital, University of Turin, Orbassano, Turin, Italy.
Sergio SerniDepartment of Urology, Careggi Hospital, University of Florence, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo explore the perspective of urological patients on the possibility to defer elective surgery due to the fear of contracting COVID-19.

methodsAll patients scheduled for elective urological procedures for malignant or benign diseases at 2 high-volume centers were administered a questionnaire, through structured telephone interviews, between April 24 and 27, 2020. The questionnaire included 3 questions: (1) In light of the COVID-19 pandemic, would you defer the planned surgical intervention? (2) If yes, when would you be willing to undergo surgery? (3) What do you consider potentially more harmful for your health: the risk of contracting COVID-19 during hospitalization or the potential consequences of delaying surgical treatment?

resultsOverall, 332 patients were included (51.5% and 48.5% in the oncology and benign groups, respectively). Of these, 47.9% patients would have deferred the planned intervention (33.3% vs 63.4%; P < .001), while the proportion of patients who would have preferred to delay surgery for more than 6 months was comparable between the groups (87% vs 80%). These answers were influenced by patient age and American Society of Anesthesiologists score (in the Oncology group) and by the underlying urological condition (in the benign group). Finally, 182 (54.8%) patients considered the risk of COVID-19 potentially more harmful than the risk of delaying surgery (37% vs 73%; P < .001). This answer was driven by patient age and the underlying disease in both groups.

conclusionsOur findings reinforce the importance of shared decision-making before urological surgery, leveraging patients' values and expectations to refine the paradigm of evidence-based medicine during the COVID-19 pandemic and beyond.

Indexed as

AgedAged, 80 and overCOVID-19Decision Making, SharedElective Surgical ProceduresEvidence-Based MedicineFemaleHospitals, High-VolumeHumansInfection ControlInfectious Disease Transmission, Professional-to-PatientMaleMiddle AgedPandemicsPatient PreferenceProspective Studies

Identifiers

PMID32979378
PMCPMC7513799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.